Kevin C. Gorman

2021

In 2021, Kevin C. Gorman earned a total compensation of $14.1M as Chief Executive Officer at Neurocrine Biosciences, a 1% increase compared to previous year.

Compensation breakdown

Bonus$701,250
Option Awards$6,093,752
Salary$825,000
Stock Awards$6,406,366
Other$55,044
Total$14,081,412

Gorman received $6.4M in stock awards, accounting for 45% of the total pay in 2021.

Gorman also received $701.3K in bonus, $6.1M in option awards, $825K in salary and $55K in other compensation.

Rankings

In 2021, Kevin C. Gorman's compensation ranked 613th out of 12,415 executives tracked by ExecPay. In other words, Gorman earned more than 95.1% of executives.

ClassificationRankingPercentile
All
613
out of 12,415
95th
Division
Manufacturing
206
out of 5,505
96th
Major group
Chemicals And Allied Products
67
out of 2,375
97th
Industry group
Drugs
57
out of 2,096
97th
Industry
Biological Products, Except Diagnostic Substances
20
out of 449
96th

Pay ratio

Kevin C. Gorman's Pay$14,081,412
Median Employee's Pay$276,598
Pay Ratio

51

to 1

In 2021, the annual total compensation of Kevin C. Gorman was $14,081,412.

The annual total compensation of the median employee at Neurocrine Biosciences was $276,598.

The ratio of Kevin C. Gorman's pay to the pay of median employee was therefore 51 to one.

Source: SEC filing on April 7, 2022.

Gorman's colleagues

We found four more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2021.

2021

Jude Onyia

Neurocrine Biosciences

Chief Scientific Officer

2021

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

2021

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2021

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

News

You may also like